Tranexamic Acid Oral: Dosing and Precautions
Tranexamic acid guidance for abnormal uterine bleeding unrelated to pregnancy, with thromboembolic precautions.
Also searched as
Source reviewed
October 2021
Guide category
Oral drugs
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Antifibrinolytic.
Indications
Abnormal uterine bleeding, especially functional uterine bleeding unrelated to pregnancy.
Forms and strengths
- 500 mg tablet.
Dose and duration
- Adolescent and adult: 1 g 3 times daily, maximum 1 g 4 times daily, until bleeding stops, maximum 5 days.
Contra-indications, adverse effects, precautions
- Do not administer in patients with, or with a history of, venous or arterial thromboembolic disorders, severe renal impairment, or history of seizures.
- Reduce dosage in patients with mild to moderate renal impairment because of the risk of accumulation.
- May cause gastrointestinal disturbances, seizures with high doses, visual disturbances, and allergic reactions.
- Avoid combination with drugs that increase the risk of thromboembolism. Concomitant use of oestrogens should be carefully considered on a case-by-case basis.
- Pregnancy: this drug is not indicated in the event of bleeding during pregnancy.
- Breast-feeding: no contra-indication.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.